Top Markets
Coin of the day
Kyto Technology and Life Science, Inc. Kyto Technology and Life Science, Inc.

Kyto Technology and Life Science, Inc.

KBPH
Rank in Stocks #34729
Kyto Technology and Life Science, Inc. operates as a venture capital firm,... Kyto Technology and Life Science, Inc. operates as a venture capital firm, primarily targeting nascent and early-stage enterprises. Its investment focus lies specifically within the technology and life science sectors. The firm's funding approach offers two main options: either secured convertible debt (which accrues interest and includes a conversion discount into preferred equity) or direct investment in preferred shares. Notably, Kyto Technology and Life Science does not take the lead role in financing rounds. Its investment capital is geographically distributed, with half allocated to ventures in the United States and the remainder supporting companies in Canada and Israel. Established in 1999, the company was formerly known as Kyto BioPharma, Inc. before rebranding in April 2018. It maintains its headquarters in Los Altos Hills, California, with a secondary office located in Scotts Valley, California.
Share Price
$1.00
Last synced: 2023-05-23
Market Cap
$5.03M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Kyto Technology and Life Science, Inc. (KBPH)
Revenue for Kyto Technology and Life Science, Inc. (KBPH)
Revenue in Aug 2026 TTM: 0
According to Kyto Technology and Life Science, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Kyto Technology and Life Science, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$27.30B -
US
$16.04B -
US
- -
SE
$21.12B -
US
$5.40B -
US